ZPD A/S: Financial statements 2020
CVR: 32834825
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ZPD A/S (CVR 32834825) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 35,568,000 and a net result of DKK 5,954,000 compared with DKK 7,705,000 the year before. That is a decrease of 3.2% compared with the year before. Equity in the 2020 report amounted to DKK 171,203,000. The solvency ratio was 93.6%. The company had 34 employees in the financial year.
- Gross Profit
- DKK 35,568,000
- Profit/Loss
- DKK 5,954,000
- Equity
- DKK 171,203,000
- Total Assets
- DKK 182,960,000
- Employees
- 34
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 35.6 mio. | 6 mio. | 171.2 mio. | 34 |
| 2019 | - | 36.8 mio. | 7.7 mio. | 165.2 mio. | 33 |
| 2018 | - | 41.5 mio. | 11.4 mio. | 157.5 mio. | 32 |
| 2017 | - | 40.8 mio. | 11.2 mio. | 146.1 mio. | 28 |
| 2016 | - | 39.8 mio. | 10.9 mio. | 134.9 mio. | 28 |
Official annual report
How creditworthy is ZPD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 10, 2020, Mitsuru Iwai has joined the board of directors of ZPD A/S.
As of July 10, 2020, Katsuyuki Ishii has left the board of directors of ZPD A/S.
ZPD A/S has published its annual report for 2019. Gross profit came to DKK 36,750,000, and the net result was DKK 7,705,000.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.